VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,283 | +1229.1% | 25,644 | +3379.5% | 0.00% | – |
| Q2 2023 | $18,079 | -71.2% | 737 | -72.7% | 0.00% | – |
| Q1 2023 | $62,829 | -86.9% | 2,700 | -85.8% | 0.00% | -100.0% |
| Q4 2022 | $480,890 | +158.5% | 19,000 | +93.3% | 0.00% | – |
| Q3 2022 | $186,000 | +2.8% | 9,831 | +39.8% | 0.00% | – |
| Q2 2022 | $181,000 | -84.2% | 7,031 | -84.3% | 0.00% | -100.0% |
| Q1 2022 | $1,148,000 | +21.9% | 44,669 | +98.2% | 0.00% | 0.0% |
| Q4 2021 | $942,000 | +272.3% | 22,542 | +285.3% | 0.00% | – |
| Q3 2021 | $253,000 | -80.2% | 5,851 | -78.3% | 0.00% | -100.0% |
| Q2 2021 | $1,275,000 | -33.9% | 26,995 | -28.3% | 0.00% | -33.3% |
| Q1 2021 | $1,928,000 | +55.7% | 37,630 | -18.6% | 0.00% | +50.0% |
| Q4 2020 | $1,238,000 | +6.3% | 46,204 | +36.0% | 0.00% | -33.3% |
| Q3 2020 | $1,165,000 | +1.3% | 33,970 | +21.0% | 0.00% | 0.0% |
| Q2 2020 | $1,150,000 | – | 28,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |